Mon panier

CD155

CD155 Informations sur la molécule

Nom anglaisPoliovirus receptorNombre de médicaments commercialisés0
Nombre de médicaments cliniques2Alias de la ciblePVR Cell Adhesion Molecule,Poliovirus receptor,PVS,NECL-5,PVR,Nectin-Like Protein 5,CD155 Antigen,Nectin-Like 5,CD155,NECL5,TAGE4,HVED
Phase de R&D la plus avancéePhase 2 Clinical
Nom anglaisPoliovirus receptor
Alias de la ciblePVR Cell Adhesion Molecule,Poliovirus receptor,PVS,NECL-5,PVR,Nectin-Like Protein 5,CD155 Antigen,Nectin-Like 5,CD155,NECL5,TAGE4,HVED
Nombre de médicaments commercialisés0
Nombre de médicaments cliniques2
Phase de R&D la plus avancéePhase 2 Clinical

CD155Contexte de la molécule

CD155 is a Type I transmembrane glycoprotein in the immunoglobulin superfamily. Commonly known as Poliovirus Receptor (PVR) due to its involvement in the cellular poliovirus infection in primates, CD155's normal cellular function is in the establishment of intercellular adherens junctions between epithelial cells. CD155/PVR was originally isolated based on its ability to mediate polio virus attachment to host cells. The fulllength (or CD155 alpha isoform) is synthesized as a 417 amino acid (aa) precursor that contains a 20 aa signal sequence, a 323 aa extracellular region, a 24 aa TM segment and a 50 aa cytoplasmic tail. The extracellular region contains one N terminal V type and two C2 type Ig like domains. CD155 is a transmembrane protein with 3 extracellular immunoglobulin-like domains, D1-D3, where D1 is recognized by the virus. Low resolution structures of CD155 complexed with poliovirus have been obtained using electron microscopy while a high resolution structures of theectodomain D1 and D2 of CD155 were solved by x-ray crystallography.

CD155Alias de la molécule

PVR,FLJ25946,PVS,CD155,TAGE4,HVED,NECL5

Informations sur les médicaments cliniques

Nom anglaisCode de recherchePhase de R&DEntrepriseIndicationEssai clinique
LerapolturevPhase 2 ClinicalDuke University Medical Center, Istari Oncology Inc, National Cancer InstituteAstrocytoma; Brain Neoplasms; Breast Neoplasms; Carcinoma, Embryonal; Ependymoma; Glioblastoma; Glioma; Gliosarcoma; Medulloblastoma; Melanoma; Oligodendroglioma; Solid tumours; Urinary Bladder Neoplasms
Details
NTX-1088Phase 1 ClinicalNectin Therapeutics LtdNeoplasm Metastasis; Neoplasms; Solid tumours
Details

Avis sur les produits

  • Informations sur la molécule
  • Liste de produits
  • Avis sur les produits
  • Informations sur les médicaments cliniques